Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Myc matters in HIV-associated lymphoma
Thomas E. Witzig
Hematology
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Myc matters in HIV-associated lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Histone Deacetylase Inhibitors
100%
Vorinostat
80%
Lymphoma
71%
HIV
58%
Lymphoma, Large B-Cell, Diffuse
32%
Rituximab
30%
Vincristine
30%
Etoposide
30%
Prednisone
29%
Human Herpesvirus 4
28%
Cyclophosphamide
26%
Doxorubicin
26%
Progression-Free Survival
25%
HIV Infections
25%
Survival Rate
21%
Survival
15%
Neoplasms
9%
Chemical Compounds
Vorinostat
98%
Histone
91%
Prednisone
44%
Vincristine
42%
Cyclophosphamide
39%
Etoposide
39%